Synthetic multivalent antifungal peptides effective against fungi

PLoS ONE

Volumn 9, Issue 2, 2014, Pages

  Lakshminarayanan, Rajamani ^a,b   Liu, Shouping ^a,b   Li, Jianguo ^a,c   Nandhakumar, Muruganantham ^a   Aung, Thet Tun ^a   Goh, Eunice ^a   Chang, Jamie Ya Ting ^a   Saraswathi, Padhmanaban ^a   Tang, Charles ^e,h   Safie, Siti Radiah Binte ^a   Lin, Lim Yih ^a   Riezman, Howard ^d   Lei, Zhou ^a,b   Verma, Chandra S ^c,f,g   Beuerman, Roger W ^a,b,f  

^a SINGAPORE EYE RESEARCH INSTITUTE   (Singapore)

^b DUKE NUS MEDICAL SCHOOL   (Singapore)

^c BIOINFORMATICS INSTITUTE   (Singapore)

^d UNIVERSITY OF GENEVA   (Switzerland)

^e SINGAPORE GENERAL HOSPITAL   (Singapore)

^f NANYANG TECHNOLOGICAL UNIVERSITY   (Singapore)

^g NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^h ALS Food and Pharmaceuticals   (Singapore)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE TRIPHOSPHATE; AMPHOTERICIN B; ANTIFUNGAL AGENT; ARGININE; CALCEIN; NATAMYCIN; STEROL; TETRAVALENT PEPTIDE B4010; TRYPSIN; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIFUNGAL ACTIVITY; ANTIFUNGAL SUSCEPTIBILITY; ARTICLE; BILAYER MEMBRANE; CANDIDA ALBICANS; CELL MEMBRANE POTENTIAL; CONCENTRATION RESPONSE; CONJUNCTIVA EPITHELIUM; CONTROLLED STUDY; CORNEA INJURY; DRUG CYTOTOXICITY; DRUG DESIGN; DRUG EFFICACY; DRUG HYPERSENSITIVITY; EPITHELIUM CELL; FUNGUS MUTANT; HEMOLYSIS; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; LACRIMAL FLUID; MALE; MEMBRANE DAMAGE; MINIMUM INHIBITORY CONCENTRATION; MOLECULAR DYNAMICS; NONHUMAN; PROTEIN CARBOHYDRATE INTERACTION; PROTEIN INTERACTION; RABBIT; SACCHAROMYCES CEREVISIAE; SERUM; WOUND HEALING;

ANIMALS; ANTIFUNGAL AGENTS; CALORIMETRY; CANDIDA ALBICANS; CELL MEMBRANE; CELLS, CULTURED; CIRCULAR DICHROISM; CONJUNCTIVA; ELECTROPHORESIS, POLYACRYLAMIDE GEL; EPITHELIAL CELLS; HEMOLYSIS; HUMANS; LIPID BILAYERS; MICE; MICE, INBRED C57BL; MICROBIAL SENSITIVITY TESTS; MOLECULAR DYNAMICS SIMULATION; PEPTIDE FRAGMENTS; RABBITS; SACCHAROMYCES CEREVISIAE; WOUND HEALING;

EID: 84894630766     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0087730     Document Type: Article

References (59)

1. Miceli MH, Diaz JA, Lee SA (2011) Emerging opportunistic yeast infections. Lancet Infect. Dis. 11: 142-151.
2. Bassetti M, Righi E, Costa A, Fasce R, Molinari MP, et al. (2006) BMC Epidemiological trends in nosocomial candidemia in intensive care. Infect. Dis. 6: 21.
3. McNeil MM, Nash SL, Hajjeh RA, Phelan MA, Conn LA, et al. (2001) Trends in mortality due to invasive mycotic diseases in the United States, 1980-1997. Clin. Infect. Dis. 33: 641-647. (Pubitemid 32762937)
4. Fisher MC, Henk DA, Briggs CJ, Brownstein JS, Madoff LC, et al. (2012) Emerging fungal threats to animal, plant and ecosystem health. Nature. 484: 186-194.
5. Ostrosky-Zeichner L, Casadevall A, Galgiani JN, Odds FC, Rex JH (2010) An insight into the antifungal pipeline: selected new molecules and beyond. Nat. Rev. Drug. Discov. 9: 719-727.
6. Masia M, Canuto F, Gutierrez Rodero (2002) Antifungal drug resistance to azoles and polyenes. Lancet Infect. Dis. 2: 550-563.
7. Verweij PE, Mellado E, Melchers WJ (2007) Multiple-triazole-resistant aspergillosis. N. Engl. J. Med. 356: 1481-1483.
8. Fjell CD, Hiss JA, Hancock RE, Schneider G (2011) Designing antimicrobial peptides: form follows function. Nat. Rev. Drug Discov. 11: 37-51.
9. Wimley WC, Hristova K (2011) Antimicrobial peptides: successes, challenges and unanswered questions. J. Membr. Biol. 239: 27-34.
10. Eckert R (2011) Road to clinical efficacy: challenges and novel strategies for antimicrobial peptide development. Future Microbiol. 6: 635-651.
11. Bals R, Weiner DJ, Meegalla RL, Accurso F, Wilson JM (2001) Salt-independent abnormality of antimicrobial activity in cystic fibrosis airway surface fluid. Am. J. Respir. Cell Mol. Biol. 25: 21-25. (Pubitemid 32682701)
12. Tang JX, Wen Q, Bennett A, Kim B, Sheils CA, et al. (2005) Anionic poly(amino acid)s dissolve F-actin and DNA bundles, enhance DNase activity, and reduce the viscosity of cystic fibrosis sputum. Am J Physiol Lung Cell Mol Physiol. 289: 599-605.
13. Knappe D, Henklein P, Hoffmann R, Hilpert K (2010) Easy strategy to protect antimicrobial peptides from fast degradation in serum. Antimicrob Agents Chemother. 54: 4003-4005.
14. Chongsiriwatana NP, Wetzler M, Barron AE (2011) Functional synergy between antimicrobial peptoids and peptides against Gram-negative bacteria. Antimicrob Agents Chemother. 55: 5399-5402.
15. Oh JE, Lee KH (1999) Synthesis of novel unnatural amino acid as a building block and its incorporation into an antimicrobial peptide. Biorg. Med. chem. 12: 2985-2990. (Pubitemid 30105873)
16. Kindrachuk J, Scruten E, Attah-Poku S, Bell K, Potter A, et al. (2011) Stability, toxicity, and biological activity of host defense peptide BMAP28 and its inversed and retro-inversed isomers. Biopolymers. 96: 14-24.
17. Makovitzki A, Avrahami D, Shai Y (2006) Ultrashort antibacterial and antifungal lipopeptides. Proc Natl Acad Sci U S A. 103: 15997-16002. (Pubitemid 44657581)
18. Liu Z, Young AW, Hu P, Rice AJ, Zhou C, et al. (2007) Tuning the membrane selectivity of antimicrobial peptides by using multivalent design. ChemBioChem. 8: 2063-2065. (Pubitemid 350220756)
19. Mintzer MA, Dane EL, O'Toole GA, Grinstaff MW (2012) Tuning the membrane selectivity of antimicrobial peptides by using multivalent design. Mol. Pharm. 9: 342-354.
20. Giulliani A, Rinaldi AC (2011) Beyond natural antimicrobial peptides: multimeric peptides and other peptidomimetic approaches. Cell Mol. Life Sci. 68: 2255-2256.
21. Niederhafner P, Bednárová L, Buděší nský M, Safařík M, Ehala S, et al. (2010) Melectin MAPs: the influence of dendrimerization on antimicrobial and hemolytic activity. Amino Acids. 39: 1553-1561.
22. Stach M, Maillard N, Kadam R U, Kalbermatter D, Meury M, et al. (2012) Membrane disrupting antimicrobial peptide dendrimers with multiple amino termini. MedChemCom. 3: 86-89.
23. Verwer PE, Woodle MC, Boekhout T, Hagen F, Bakker-Woudenberg IA, et al. (2011) Cryptococcus and Trichosporon spp. are susceptible in vitro to branched histidine- and lysine-rich peptides (BHKPs). J Antimicrob Chemother. 66: 1649-1652.
24. Arnusch CJ, Albada HB, Van Vaardegem M, Liskamp RM, Sahl HG, et al. (2012) Trivalent ultrashort lipopeptides are potent pH dependent antifungal agents. J. Med. Chem. 55: 1296-1302.
25. Bai Y, Liu S, Jiang P, Zhou L, Li J, et al. (2009) Structure-dependent charge density as a determinant of antimicrobial activity of peptide analogues of defensin. Biochemistry. 48: 7229-7239.
26. Zhou L, Liu SP, Chen LY, Li J, Ong LB, et al. (2011) The structural parameters for antimicrobial activity, human epithelial cell cytotoxicity and killing mechanism of synthetic monomer and dimer analogues derived from hBD3 C-terminal region. Amino Acids. 40: 123-133.
27. Nguyen LT, Chau JK, Perry NA, De Boer L, Zaat SA, et al. (2010) Serum stabilities of short tryptophan- and arginine-rich antimicrobial peptide analogs. PLoS One. 5: e12684.
28. Guan XL, Souza CM, Pichler H, Dewhurst G, Schaad O, et al. (2009) Functional interactions between sphingolipids and sterols in biological membranes regulating cell physiology. Mol. Biol. Cell. 20: 2083-2095.
29. Te Welcher YM, Ten Napel HH, Balague MM, Souza CM, Riezman H, et al. (2008) Natamycin blocks fungal growth by binding specifically to ergosterol without permeabilizing the membrane.J. Biol. Chem. 283: 6393-6401.
30. Oren Z, Shai Y (1997) Selective lysis of bacteria but not mammalian cells by diastereomers of melittin: structure-function study. Biochemistry. 36: 1826-1835. (Pubitemid 27086279)
31. Diebold Y, Calonge M, Enríquez de Salamanca A, Callejo S, Corrales RM, et al. (2003) Characterization of a spontaneously immortalized cell line (IOBA-NHC) from normal human conjunctiva. Invest Ophthalmol Vis Sci. 44: 4263-74. (Pubitemid 37186260)
32. Crosson CE, Klyce SD, Beuerman RW (1986) Epithelial wound closure in the rabbit cornea. A biphasic process. Invest Ophthalmol Vis Sci. 27, 464-473. (Pubitemid 16116289)
33. Koshlukova SE, Lloyd TL, Araujo MW, Edgorton M (1999) Salivary histatin 5 induces non-lytic release of ATP from Candida albicans leading to cell death. J. Biol. Chem. 274: 18872-18879.
34. Li J, Lakshminarayanan R, Bai Y, Liu S, Zhou L, et al. (2012) Molecular dynamics simulations of a new branched antimicrobial peptide: A comparison of force fields. J Chem Phys. 137: 215101.
35. Klauda JB, Venable RM, Freites JA, O'Connor JW, Tobias DJ, et al. (2010) Update of the CHARMM all-atom additive force field for lipids: validation on six lipid types. J. Phys. Chem. B. 114: 7830-7843.
36. Bjelkmar P, Larsson P, Cuendet MA, Hess B, Lindahl E (2010) Implementation of the CHARMM Force Field in GROMACS: Analysis of Protein Stability Effects from Correction Maps, Virtual Interaction Sites, and Water Models. J. Chem. Theory Comput. 6: 459-466.
37. Essmann U, Perera L, Berkowitz ML, Darden T, Lee H, et al. (1995) A smooth particle mesh Ewald method. J. Chem. Phys. 103: 8577-8593.
38. Hess B, Bekker H, Berendsen HJC, Fraaije JGEM (1997) LINCS: A linear constraint solver for molecular simulations. J. Comput. Chem. 18: 1463-1472. (Pubitemid 127637344)
39. Nosé S, Klein ML (1983) Constant pressure molecular-dynamics for molecular systems. Mol. Phy. 50: 1055-1076.
40. Li J, Liu S, Lakshminarayanan R, Bai Y, Pervushin K, et al. (2012) Molecular simulations suggest how a branched antimicrobial peptide perturbs a bacterial membrane and enhances permeability. Biochim Biophys Acta. 1828: 1112-1121.
41. Arora R, Gupta D, Goyal J, Kaur R (2011) Voriconazole versus natamycin as primary treatment in fungal corneal ulcers. Clin. Experiment. Ophthamol. 39: 434-440.
42. Roth BL, Poot M, Yue ST, Millard PJ (1997) Bacterial viability and antibiotic susceptibility testing with SYTOX green nucleic acid stain. Appl. Environ. Microbiol. 63: 2421-2431. (Pubitemid 27232947)
43. Veerman EC, Valentijn-Benz M, Nazmi K, Ruissen AL, Walgreen-Weterings E, et al. (2007) Energy depletion protects Candida albicans against antimicrobial peptides by rigidifying its cell membrane. J Biol Chem. 282: 18831-18841. (Pubitemid 47100165)
44. Tsai CW, Hsu NY, Wang CH, Lu CY, Chang Y, et al. Coupling molecular dynamics simulations with experiments for the rational design of indolicidin-analogous antimicrobial peptides. J Mol Biol. 2009; 392: 837-54.
45. Wang Y, Schlamadinger DE, Kim JE, McCammon JA (2012) Comparative molecular dynamics simulations of the antimicrobial peptide CM15 in model lipid bilayers. Biochim Biophys Acta.; 1818: 1402-9.
46. Lupi O, Tyring SK, McGinnis MR (2005) Tropical dermatology: fungal tropical diseases. J Am Acad Dermatol. 53: 931-951.
47. Zaoutis TE, Argon J, Chu J, Berlin JA, Walsh TJ, et al. (2005) The epidemiology and attributable outcomes of candidemia in adults and children hospitalized in the United States: a propensity analysis. Clin. Infect. Dis. 41: 1232-1239. (Pubitemid 41532664)
48. Pfaller MA, Diekema DJ (2007) Epidemiology of invasive candidiasis: a persistent public health problem. Clin Microbiol Rev. 20: 133-163. (Pubitemid 46167771)
49. Huang LC, Jean D, Proske RJ, Reins RY, McDermott AM (2007) Ocular surface expression and in vitro activity of antimicrobial peptides. Curr Eye Res. 32: 595-609. (Pubitemid 47400679)
50. Gásková D, Brodská B, Herman P, Vecer J, Malínský J, et al. (1998) Fluorescent probing of membrane potential in walled cells: diS-C3(3) assay in Saccharomyces cerevisiae. Yeast. 14: 1189-1197. (Pubitemid 28435041)
51. Tam JP, Lu YA, Yang JL (2002) Antimicrobial dendrimeric peptides. Eur. J. Biochem. 269: 923-932. (Pubitemid 34175413)
52. Falciani C, Lozzi L, Pini A, Corti F, Fabbrini M, et al. (2007) Molecular basis of branched peptides resistance to enzyme proteolysis. Chem Biol Drug Des. 69: 216-221. (Pubitemid 46608454)
53. Kelly SL, Lamb DC, Kelly DE, Manning NJ, Loeffler J, et al. (1997) Resistance to fluconazole and cross-resistance to amphotericin B in Candida albicans from AIDS patients caused by defective sterol delta5,6-desaturation. FEBS Lett. 400: 80-82. (Pubitemid 27046825)
54. Nolte FS, Parkinson T, Falconer DJ, Dix S, Williams J, et al. (1997) Isolation and characterization of fluconazole- and amphotericin B-resistant Candida albicans from blood of two patients with leukemia. Antimicrob Agents Chemother. 4: 196-199. (Pubitemid 26428157)
55. Mukhopadhyay K, Kohli A, Prasad R (2002) Drug susceptibilities of yeast cells are affected by membrane lipid composition. Antimicrob Agents Chemother. 46: 3695-3705. (Pubitemid 35403239)
56. Li XS, Reddy MS, Baev D, Edgerton M (2003) Candida albicans Ssa1/2p is the cell envelope binding protein for human salivary histatin 5. J Biol Chem. 278: 28553-28561. (Pubitemid 36935760)
57. van der Weerden NL, Hancock RE, Anderson MA (2010) Permeabilization of fungal hyphae by the plant defensin NaD1 occurs through a cell wall-dependent process. J Biol Chem. 285: 37513-37520.
58. Vacata V, Kotyk A, Sigler K (1981) Membrane potentials in yeast cells measured by direct and indirect methods. Biochim Biophys Acta. 643: 265-268. (Pubitemid 11124224)
59. Prasad R, Höfer M (1986) Tetraphenylphosphonium is an indicator of negative membrane potential in Candida albicans. Biochim Biophys Acta. 861: 377-380.